I'm certainly not a professional trader. But I'm
Post# of 153818
(Total Views: 481)
Posted On: 04/03/2020 11:56:35 AM
I'm certainly not a professional trader. But I'm wondering if what we saw yesterday was less about shorting and more about just manipulation?
Would it be possible that someone that was looking to buy a lot of shares and I mean a lot. Could buy large amounts of shares and then alternate patterns of selling with buying. Always with the goal of buying more shares than selling over a period of time. If I was a really big fish trying to accumulate CYDY shares, wouldn't it make sense to do it that way.
As I've watched the stock through the years, the games I've seen played have looked more like attempts to create attractive entry points than to short the stock.
Personally, I have a very large core long-term position in CYDY but I do take the opportunity to trade a very small position and ride the ups and downs.
I really don't care about the short-term share price. The only thing I care about in terms of the short-term share price is the effect it has on the company's ability to raise funds at attractive valuations.
If Leronlimab is what we all think it is the share price will take care of itself. In the meantime, I'm happy to use these "attacks" as an opportunity to trade small positions.
Would it be possible that someone that was looking to buy a lot of shares and I mean a lot. Could buy large amounts of shares and then alternate patterns of selling with buying. Always with the goal of buying more shares than selling over a period of time. If I was a really big fish trying to accumulate CYDY shares, wouldn't it make sense to do it that way.
As I've watched the stock through the years, the games I've seen played have looked more like attempts to create attractive entry points than to short the stock.
Personally, I have a very large core long-term position in CYDY but I do take the opportunity to trade a very small position and ride the ups and downs.
I really don't care about the short-term share price. The only thing I care about in terms of the short-term share price is the effect it has on the company's ability to raise funds at attractive valuations.
If Leronlimab is what we all think it is the share price will take care of itself. In the meantime, I'm happy to use these "attacks" as an opportunity to trade small positions.
(2)
(0)